Role of BAALC Gene in Prognosis of Acute Lymphoblastic Leukemia in Egyptian Children

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2018 Feb 6

PMID 29398800

Citations 1

Authors

Adel A Hagag

Walid A Elshehaby

Nahd M Hablas

Mohamed M Abdelmageed

Amal Ezzat Abd El-Lateef

Affiliations

Soon will be listed here.

Abstract

Acute lymphoblastic leukemia (ALL) is characterized by excess bone marrow lymphoblast cell production. Brain and Acute Leukemia Cytoplasmic gene (BAALC gene) is a recently identified gene on chromosome 8q22.3. The aim of this work was to study the role of BAALC gene in prognosis of ALL in Egyptian children. This study was conducted on 60 children with ALL who were admitted in Oncology Unit in the period from January 2012 to March 2015 including 36 males and 24 females with mean age of 8.74 ± 2.66 years. For all patients the following were done: Full history taking, thorough clinical examination and laboratory investigations including: complete blood count, LDH, bone marrow aspiration, cytochemistry, immunophenotyping, FISH technique for detection of t(12;21) and t(9;22) and assessment of BAALC gene expression by PCR in bone marrow aspirate mononuclear cells at diagnosis before chemotherapy. Positive BAALC gene expression was found in 36 patients (60%) and negative expression in 24 patients (40%). Positive BAALC gene expression group includes 14 males and 22 females with mean age at presentation of 8.45 ± 2.77 years while negative BAALC gene expression group includes 18 males and 6 females with mean age at presentation of 8.61 ± 2.44 years with no significant differences between positive and negative BAALC gene expression groups regarding age, sex, clinical presentations, WBCs and platelets counts, hemoglobin and LDH levels, peripheral blood and BM blast cell counts, immunophenotyping and chromosomal translocations including t(12;21) and t(9;22). There were significant differences in disease outcome between positive and negative BAALC gene expression groups with higher rate of relapse and death and lower rate of complete remission, disease free survival (DFS) and overall survival (OS) in positive BAALC gene expression group compared with negative group ( = 0.028). Multivariate analyses for overall survival and disease free survival shows significant role of BAALC gene expression in OS and DFS. BAALC expression might represent an additional prognostic marker in children with ALL and should be routinely assessed at diagnosis for better prognostic assessment.

Citing Articles

Novel gene signature reveals prognostic model in acute lymphoblastic leukemia.

Chen P, Gao G, Xu Y, Jia P, Li Y, Li Y Front Cell Dev Biol. 2022; 10:1036312.

PMID: 36407095 PMC: 9669305. DOI: 10.3389/fcell.2022.1036312.

References

Xiao S, Shen J, Huang J, Fu H . Prognostic significance of the gene expression in adult patients with acute myeloid leukemia: A meta-analysis. Mol Clin Oncol. 2015; 3(4):880-888. PMC: 4486884. DOI: 10.3892/mco.2015.562. View

Pui C, Howard S . Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008; 9(3):257-68. DOI: 10.1016/S1470-2045(08)70070-6. View

Goldberg J, Silverman L, Levy D, Dalton V, Gelber R, Lehmann L . Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 2003; 21(19):3616-22. DOI: 10.1200/JCO.2003.10.116. View

Chauvenet A, Martin P, Devidas M, Linda S, Bell B, Kurtzberg J . Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood. 2007; 110(4):1105-11. PMC: 1939894. DOI: 10.1182/blood-2006-12-061689. View

Baldus C, Tanner S, Ruppert A, Whitman S, Archer K, Marcucci G . BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood. 2003; 102(5):1613-8. DOI: 10.1182/blood-2003-02-0359. View

Seibel N, Steinherz P, Sather H, Nachman J, Delaat C, Ettinger L . Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2007; 111(5):2548-55. PMC: 2254538. DOI: 10.1182/blood-2007-02-070342. View

Yahya R, Sofan M, Abdelmasseih H, Saudy N, Sharaf-Eldein M . Prognostic implication of BAALC gene expression in adult acute myeloid leukemia. Clin Lab. 2013; 59(5-6):621-8. DOI: 10.7754/clin.lab.2012.120604. View

Baldus C, Martus P, Burmeister T, Schwartz S, Gokbuget N, Bloomfield C . Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol. 2007; 25(24):3739-45. DOI: 10.1200/JCO.2007.11.5253. View

Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

10.

Tanner S, Austin J, Leone G, Rush L, Plass C, Heinonen K . BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A. 2001; 98(24):13901-6. PMC: 61139. DOI: 10.1073/pnas.241525498. View

11.

Kuhnl A, Gokbuget N, Stroux A, Burmeister T, Neumann M, Heesch S . High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(18):3737-44. DOI: 10.1182/blood-2009-09-241943. View

12.

Santamaria C, Chillon M, Garcia-Sanz R, Perez C, Caballero M, Mateos M . BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). Ann Hematol. 2009; 89(5):453-8. DOI: 10.1007/s00277-009-0864-x. View

13.

Heesch S, Schlee C, Neumann M, Stroux A, Kuhnl A, Schwartz S . BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia. Leukemia. 2010; 24(8):1429-36. DOI: 10.1038/leu.2010.130. View

14.

Eisfeld A, Marcucci G, Liyanarachchi S, Dohner K, Schwind S, Maharry K . Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2012; 109(17):6668-73. PMC: 3340094. DOI: 10.1073/pnas.1203756109. View

15.

Kosior K, Lewandowska-Grygiel M, Giannopoulos K . Tyrosine kinase inhibitors in hematological malignancies. Postepy Hig Med Dosw (Online). 2011; 65:819-28. DOI: 10.5604/17322693.968778. View

16.

Hunger S, Lu X, Devidas M, Camitta B, Gaynon P, Winick N . Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012; 30(14):1663-9. PMC: 3383113. DOI: 10.1200/JCO.2011.37.8018. View

17.

Weber S, Alpermann T, Dicker F, Jeromin S, Nadarajah N, Eder C . BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia. Blood Cancer J. 2014; 4:e173. PMC: 3913940. DOI: 10.1038/bcj.2013.71. View

18.

Goldstone A, Richards S, Lazarus H, Tallman M, Buck G, Fielding A . In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional.... Blood. 2007; 111(4):1827-33. DOI: 10.1182/blood-2007-10-116582. View

19.

Guo X, Shi P, Chen F, Zha J, Liu B, Li R . Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome. Blood Cells Mol Dis. 2014; 53(3):144-8. DOI: 10.1016/j.bcmd.2014.05.001. View

20.

Ben Abdelali R, Asnafi V, Leguay T, Boissel N, Buzyn A, Chevallier P . Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study. Blood. 2011; 118(19):5099-107. DOI: 10.1182/blood-2011-02-334219. View